Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$520,000 |
 |
Gilead SciencesGILD |
-$2B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$109M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Riley Antony A | Dec 30, 2025 | Buy | 9,680 | $26.3257 | $250,000 |
| Riley Antony A | Nov 21, 2024 | Buy | 22,514 | $5.552 | $120,000 |
FAQ - Insider Transactions
The most recent insider transaction for Forte Biosciences was conducted by Riley Antony A, who sold 9,680 shares on December 30, 2025 at a price of $26.33 per share.
Riley Antony A has bought the most FBRX stock in the last 2 years, with a total value of $380,000.
According to our estimates, the total value of insider transactions for Forte Biosciences in the last 2 years is positive, amounting to $380,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
Over the last 2 years, insider transactions for Forte Biosciences have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
